{
    "clinical_study": {
        "@rank": "156351", 
        "arm_group": [
            {
                "arm_group_label": "MOVIPREP (Morning-only dose)", 
                "arm_group_type": "Experimental", 
                "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy."
            }, 
            {
                "arm_group_label": "MOVIPREP (Split-dose)", 
                "arm_group_type": "Other", 
                "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy."
            }
        ], 
        "brief_summary": {
            "textblock": "To compare colon cleansing quality induced by the 2 different modes of MOVIPREP\u00ae intake in 5\n      colon segments prior to colonoscopy."
        }, 
        "brief_title": "Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP\u00ae Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP\u00ae Bowel Preparation", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.", 
                            "title": "MOVIPREP (Morning-only Dose)"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.", 
                            "title": "MOVIPREP (Split-dose)"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "70"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "70"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "140"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "17.41", 
                                                "@value": "50.3"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "16.26", 
                                                "@value": "49.1"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "16.79", 
                                                "@value": "49.8"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "38"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "55"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "93"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "32"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "15"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "47"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "6"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "10"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Asian"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "64"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "66"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "130"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "White"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Race/Ethnicity, Customized", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "9.36", 
                                                "@value": "171.1"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "7.83", 
                                                "@value": "165.1"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "9.07", 
                                                "@value": "168.1"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Height", 
                            "units": "cm"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "16.92", 
                                                "@value": "73.5"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "13.86", 
                                                "@value": "68.3"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "15.75", 
                                                "@value": "71.1"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Weight", 
                            "units": "kg"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "5.30", 
                                                "@value": "25.1"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "5.10", 
                                                "@value": "25.1"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "5.25", 
                                                "@value": "25.1"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Body Mass Index (BMI)", 
                            "units": "kg/m^2"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "57"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "63"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "120"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Russia"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "13"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "7"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "20"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Kazakhstan"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "The first study related publication will be a multi-center publication submitted within 24 months after conclusion or termination of a study at all sites. After such multi site publication, all proposed site publications and presentations will be submitted to sponsor for review 60 days in advance of publication. Site will remove Sponsor confidential information unrelated to study results. Sponsor can delay a proposed publication for another 60 days to preserve intellectual property."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": {
                                "ci_lower_limit": "-0.097", 
                                "ci_n_sides": "1-Sided", 
                                "ci_percent": "95", 
                                "estimate_desc": "Treatment Difference is the difference in proportion of participants with successful colon cleansing between treatments -experimental vs. control", 
                                "group_id_list": {
                                    "group_id": [
                                        "O1", 
                                        "O2"
                                    ]
                                }, 
                                "method": "Exact Farrington - Manning", 
                                "non_inferiority": "Yes", 
                                "non_inferiority_desc": "The primary endpoint was analyzed by a non-inferiority test using the exact Farrington-Manning method. Non-inferiority of the two treatments was to be concluded if the lower end of the confidence interval of the difference the experimental treatment group (morning-only dose) \u2013 control treatment group (split dose) was above a non-inferiority margin of -0.15%.", 
                                "p_value": "<0.001", 
                                "param_type": "Treatment Difference", 
                                "param_value": "0.0286"
                            }
                        }, 
                        "description": "Bowel cleansing was assessed by a blinded endoscopist through visual evaluation of 5 colon segments and scored using the Harefield Cleansing Scale (HCS): A = success, all segments clean/scored 4 or 3; B = success, \u22651 segment with liquid/semi-solid amounts of stool, fully removable, \u22651 segment scored 2; C = failure, \u22651 segment with semi-solid or solid amounts of stool, at least 1 segment scored 1; and D = failure, \u2265 1 segment with irremovable, heavy, hard stools, \u2265 1 segment scored 0. Segmental evaluation of colon cleansing scores is as follows: 4: Colon empty and clean, no remaining stool or liquid. 3: Presence of clear liquid in the gut which can be removed by suction. 2: Brown liquid or semisolid remaining amounts of stool, fully removable. 1: Semisolid amounts of stool, only partially removable, difficult to make colonoscopy; 0: Irremovable, heavy, hard stools, colonoscopy impossible. Success of cleansing was defined as Grades of bowel cleansing \u0410 and \u0412.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.", 
                                    "title": "MOVIPREP (Morning-only Dose)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.", 
                                    "title": "MOVIPREP (Split-dose)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "70"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "70"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "94.29"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "91.43"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Bowel cleansing was assessed by a blinded endoscopist through visual evaluation of 5 colon segments and scored using the Harefield Cleansing Scale (HCS): A = success, all segments clean/scored 4 or 3; B = success, \u22651 segment with liquid/semi-solid amounts of stool, fully removable, \u22651 segment scored 2; C = failure, \u22651 segment with semi-solid or solid amounts of stool, at least 1 segment scored 1; and D = failure, \u2265 1 segment with irremovable, heavy, hard stools, \u2265 1 segment scored 0. Segmental evaluation of colon cleansing scores is as follows: 4: Colon empty and clean, no remaining stool or liquid. 3: Presence of clear liquid in the gut which can be removed by suction. 2: Brown liquid or semisolid remaining amounts of stool, fully removable. 1: Semisolid amounts of stool, only partially removable, difficult to make colonoscopy; 0: Irremovable, heavy, hard stools, colonoscopy impossible. Success of cleansing was defined as Grades of bowel cleansing \u0410 and \u0412.", 
                                    "param": "Number", 
                                    "title": "Percentage of Participants With Successful Colon Cleansing", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "population": "Intent-to-treat population", 
                        "safety_issue": "No", 
                        "time_frame": "1 day (the day of colonoscopy)", 
                        "title": "Percentage of Participants With Successful Colon Cleansing", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Patient satisfaction was measured on a 100 mm visual analog scale (VAS) where 0 (left end of the line) is marked as \"totally unacceptable\" (lowest patient satisfaction of colonoscopy preparation) and 100 is \"fully acceptable\" (highest patient satisfaction with the procedure). Satisfaction was scored based on a mark placed on the line by the participant.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.", 
                                    "title": "MOVIPREP (Morning-only Dose)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.", 
                                    "title": "MOVIPREP (Split-dose)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "70"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "69"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "20.97", 
                                                        "@value": "81.2"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "23.18", 
                                                        "@value": "79.6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Patient satisfaction was measured on a 100 mm visual analog scale (VAS) where 0 (left end of the line) is marked as \"totally unacceptable\" (lowest patient satisfaction of colonoscopy preparation) and 100 is \"fully acceptable\" (highest patient satisfaction with the procedure). Satisfaction was scored based on a mark placed on the line by the participant.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Patient Satisfaction of Colonoscopy Preparation (VAS)", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Intent-to-treat population with available VAS data.", 
                        "safety_issue": "No", 
                        "time_frame": "1 day (the day of colonoscopy)", 
                        "title": "Patient Satisfaction of Colonoscopy Preparation (VAS)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Compliance score = 100 * (total amount MOVIPREP\u00ae intake) / (planned MOVIPREP intake).\nTotal compliance score of MOVIPREP is the average score of the compliance for the first and second litre.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.", 
                                    "title": "MOVIPREP (Morning-only Dose)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.", 
                                    "title": "MOVIPREP (Split-dose)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "70"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "69"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "6.10", 
                                                        "@value": "98.1"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "2.66", 
                                                        "@value": "99.5"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Compliance score = 100 * (total amount MOVIPREP\u00ae intake) / (planned MOVIPREP intake).\nTotal compliance score of MOVIPREP is the average score of the compliance for the first and second litre.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Total Compliance Score", 
                                    "units": "units on a scale"
                                }
                            ]
                        }, 
                        "population": "Intent-to-treat with available data", 
                        "safety_issue": "No", 
                        "time_frame": "1 day (the day of colonoscopy)", 
                        "title": "Total Compliance Score", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "To prevent any potential dehydration risk participants were recommended the intake of at least 500 ml of additional clear liquid (juices without pulp, tea, water) per liter of the Moviprep solution. The amount of additional clear liquid taken is reported for each liter of Moviprep taken.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.", 
                                    "title": "MOVIPREP (Morning-only Dose)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.", 
                                    "title": "MOVIPREP (Split-dose)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "70"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "69"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "128.6", 
                                                            "@value": "545.43"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "243.4", 
                                                            "@value": "640.29"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "After first liter of study drug"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@spread": "116.5", 
                                                            "@value": "539.71"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@spread": "145.2", 
                                                            "@value": "585.65"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "After second liter of study drug"
                                            }
                                        ]
                                    }, 
                                    "description": "To prevent any potential dehydration risk participants were recommended the intake of at least 500 ml of additional clear liquid (juices without pulp, tea, water) per liter of the Moviprep solution. The amount of additional clear liquid taken is reported for each liter of Moviprep taken.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Patient Compliance \u2013 Amount of Additional Clear Liquid Consumed", 
                                    "units": "ml"
                                }
                            ]
                        }, 
                        "population": "Intent-to-treat population with available data", 
                        "safety_issue": "No", 
                        "time_frame": "1 day (the day of colonoscopy)", 
                        "title": "Patient Compliance \u2013 Amount of Additional Clear Liquid Consumed", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "An AE was a worsening in severity or frequency of a concomitant illness or any new illness diagnosed during the clinical trial period. A serious adverse event (SAE) is any untoward medical occurrence or effect that at any dose results in death; is life threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability / incapacity; is a congenital anomaly / birth defect; is medically important. Severity is a clinical observation and describes the intensity of the event: Mild: Transient symptoms, no interference with daily activities; Moderate: Marked symptoms, moderate interference with daily activities; Severe: Considerable interference with daily activities. Relatedness to study drug was assessed by the Investigator.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.", 
                                    "title": "MOVIPREP (Morning-only Dose)"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.", 
                                    "title": "MOVIPREP (Split-dose)"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "70"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "70"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "58.6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "61.4"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Any adverse event (AE)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "52.9"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "54.3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Mild adverse event"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "5.7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "7.1"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Moderate adverse event"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0.0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0.0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Severe adverse event"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0.0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "0.0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Serious adverse event"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0.0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "1.4"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "AE leading to study discontinuation"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "57.1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@value": "58.6"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Treatment-related adverse event"
                                            }
                                        ]
                                    }, 
                                    "description": "An AE was a worsening in severity or frequency of a concomitant illness or any new illness diagnosed during the clinical trial period. A serious adverse event (SAE) is any untoward medical occurrence or effect that at any dose results in death; is life threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability / incapacity; is a congenital anomaly / birth defect; is medically important. Severity is a clinical observation and describes the intensity of the event: Mild: Transient symptoms, no interference with daily activities; Moderate: Marked symptoms, moderate interference with daily activities; Severe: Considerable interference with daily activities. Relatedness to study drug was assessed by the Investigator.", 
                                    "param": "Number", 
                                    "title": "Percentage of Patients Who Experienced Adverse Events (AEs)", 
                                    "units": "percentage of participants"
                                }
                            ]
                        }, 
                        "population": "Safety population", 
                        "safety_issue": "Yes", 
                        "time_frame": "From first dose of study drug until the end of colonoscopy procedure, maximum of 24 hours.", 
                        "title": "Percentage of Patients Who Experienced Adverse Events (AEs)", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.", 
                            "title": "MOVIPREP (Morning-only Dose)"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.", 
                            "title": "MOVIPREP (Split-dose)"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": {
                                "participants_list": {
                                    "participants": [
                                        {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }, 
                                        {
                                            "@count": "1", 
                                            "@group_id": "P2"
                                        }
                                    ]
                                }, 
                                "title": "Adverse Event"
                            }
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "70", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "70", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "70", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "69", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "Participants indicated for a colonoscopy were enrolled equally in 1 of 2 treatment groups, morning-only on the day of the clinical procedure or split-dosing in 2 stages with a nocturnal pause.", 
                "recruitment_details": "Participants took part in the study at 6 investigative sites in the Russian Federation and the Republic of Kazakhstan from 22 November 2012 to 5 April 2013."
            }, 
            "point_of_contact": {
                "email": "clinicaltrialregistry@tpna.com", 
                "name_or_title": "Medical Director", 
                "organization": "Takeda", 
                "phone": "800-778-2860"
            }, 
            "reported_events": {
                "desc": "At each visit the investigator had to document any occurrence of adverse events and abnormal laboratory findings. Any event spontaneously reported by the participant or observed by the investigator was recorded, irrespective of the relation to study treatment.", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), twice within same morning of colonoscopy.", 
                            "title": "MOVIPREP (Morning-only Dose)"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "MOVIPREP 250 ml solution every 15 minutes for up to one hour (4 doses in 1 hour=1 litre of solution), once the evening before colonoscopy and once the morning of colonoscopy.", 
                            "title": "MOVIPREP (Split-dose)"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "41", 
                                                "@subjects_at_risk": "70"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "43", 
                                                "@subjects_at_risk": "70"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "26", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Abdominal discomfort"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Abdominal pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Abdominal tenderness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Gastritis erosive"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "30", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "22", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Vomiting"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Product taste abnormal"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Pyrexia"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "70"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "70"
                                            }
                                        ], 
                                        "sub_title": "Respiratory Tract Infection"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Alanine aminotransferase increased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Aspartate aminotransferase increased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Blood calcium decreased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Blood calcium increased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Blood chloride increased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Blood creatinine increased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Blood glucose increased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Blood iron decreased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Blood iron increased"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "70"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "70"
                                                }
                                            ], 
                                            "sub_title": "Body temperature increased"
                                        }
                                    ]
                                }, 
                                "title": "Investigations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "70"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "70"
                                            }
                                        ], 
                                        "sub_title": "Asthma"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "default_vocab": "MedDRA 15.0", 
                    "frequency_threshold": "0"
                }, 
                "time_frame": "From the first dose of study drug until the end of the colonoscopy, maximum of 24 hours."
            }
        }, 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel.", 
        "detailed_description": {
            "textblock": "All participants enrolled to the study will be allocated to one of two arms. Patients of the\n      experimental morning-only regimen arm will prepare and take MOVIPREP\u00ae solution in the full\n      dose - 2 litres of MOVIPREP\u00ae preparation in the early morning on the day of the colonoscopy\n      clinical procedure. Participants in the standard split-dose regimen arm will prepare and\n      take MOVIPREP\u00ae solution in  split doses - \u00bd of dose (1 litre) the evening before + \u00bd of dose\n      (1 litre) of MOVIPREP\u00ae preparation in the morning of the day of the colonoscopy.\n\n      The study consists of three visits. Participation in the study lasts no more than 11 days; 3\n      days as minimum.\n\n      There is no follow-up period planned except in case of any adverse events (AEs) when the\n      follow-up period will last until the participant has recovered or until all AE-related\n      queries for the participant have been resolved."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  male or female \u226518 years and \u2264 85 years\n\n          -  colonoscopy procedure indicated\n\n          -  willing to stay in the outpatient clinical site for colonoscopy and questionnaire\n             completion\n\n          -  willing and able to undergo study-related procedures\n\n          -  informed consent signed by a patient for participation in the study\n\n          -  negative pregnancy test in women with childbearing potential and consent for double\n             barrier method birth control for subjects, men and women, during the study\n\n        Exclusion Criteria:\n\n          -  ileus\n\n          -  suspected colonic tumor with manifestations of intestinal obstruction\n\n          -  delayed gastric emptying (gastroparesis), weak vomiting reflex, tendency to\n             aspiration and regurgitation\n\n          -  toxic megacolon which is a result of severe inflammatory conditions of the colon\n             including Crohn's disease and ulcerative colitis\n\n          -  suspected intestinal perforation or risk of gastrointestinal perforation\n\n          -  signs of severe intestinal bleeding\n\n          -  acute inflammatory anal or perianal pathology\n\n          -  severe concomitant diseases of internal organs\n\n          -  psychiatric diseases in aggravation stage\n\n          -  hypersensitivity to polyethylene glycol and/or any component of MOVIPREP\u00ae preparation\n\n          -  phenylketonuria or diagnosed glucose-6-phosphate dehydrogenate deficiency\n\n          -  unconsciousness\n\n          -  dehydration\n\n          -  severe inflammatory diseases\n\n          -  acute abdominal pain of unknown etiology\n\n          -  pregnancy and lactation period\n\n          -  participation in any other clinical study (including studies of experimental devices)\n             in 30 days prior participation in the present trial\n\n          -  patients who test positive for human immunodeficiency virus (HIV)/autoimmune disease\n             (AID), Wasserman reaction (RW) or hepatitis B virus (HBC)\n\n          -  any condition or circumstance that, in the opinion of the Investigator, would\n             compromise the safety of the participant or the quality of study data"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 19, 2012", 
        "firstreceived_results_date": "April 5, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01732692", 
            "org_study_id": "MV-9999-301-RU", 
            "secondary_id": "U1111-1135-2011"
        }, 
        "intervention": {
            "arm_group_label": [
                "MOVIPREP (Morning-only dose)", 
                "MOVIPREP (Split-dose)"
            ], 
            "description": "MOVIPREP solution", 
            "intervention_name": "MOVIPREP", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Bowel preparation, MOVIPREP\u00ae", 
        "lastchanged_date": "April 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Alma Ata", 
                        "country": "Kazakhstan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint-Petersburg", 
                        "country": "Russian Federation"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint-Petersburg,", 
                        "country": "Russian Federation"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Kazakhstan", 
                "Russian Federation"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Multicenter Endoscopist-blinded Randomized Parallel-group Comparative Study to Assess Efficacy, Safety and Tolerance of Morning-only Dosing Compared to Control Split-dosing With Nocturnal Pause in MOVIPREP\u00ae Bowel Preparation Prior to Colonoscopy", 
        "overall_official": {
            "affiliation": "Takeda", 
            "last_name": "Medical Director Clinical Science", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Russian Federation: The Ministry of Healthcare of the Russian Federation", 
                "Republic of Kazakhstan: The Ministry of Healthcare of the Republic of Kazakhstan"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Bowel cleansing was assessed by a blinded endoscopist through visual evaluation of 5 colon segments and scored using the Harefield Cleansing Scale (HCS): A = success, all segments clean/scored 4 or 3; B = success, \u22651 segment with liquid/semi-solid amounts of stool, fully removable, \u22651 segment scored 2; C = failure, \u22651 segment with semi-solid or solid amounts of stool, at least 1 segment scored 1; and D = failure, \u2265 1 segment with irremovable, heavy, hard stools, \u2265 1 segment scored 0. Segmental evaluation of colon cleansing scores is as follows: 4: Colon empty and clean, no remaining stool or liquid. 3: Presence of clear liquid in the gut which can be removed by suction. 2: Brown liquid or semisolid remaining amounts of stool, fully removable. 1: Semisolid amounts of stool, only partially removable, difficult to make colonoscopy; 0: Irremovable, heavy, hard stools, colonoscopy impossible. Success of cleansing was defined as Grades of bowel cleansing \u0410 and \u0412.", 
            "measure": "Percentage of Participants With Successful Colon Cleansing", 
            "safety_issue": "No", 
            "time_frame": "1 day (the day of colonoscopy)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01732692"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Patient satisfaction was measured on a 100 mm visual analog scale (VAS) where 0 (left end of the line) is marked as \"totally unacceptable\" (lowest patient satisfaction of colonoscopy preparation) and 100 is \"fully acceptable\" (highest patient satisfaction with the procedure). Satisfaction was scored based on a mark placed on the line by the participant.", 
                "measure": "Patient Satisfaction of Colonoscopy Preparation (VAS)", 
                "safety_issue": "No", 
                "time_frame": "1 day (the day of colonoscopy)"
            }, 
            {
                "description": "Compliance score = 100 * (total amount MOVIPREP\u00ae intake) / (planned MOVIPREP intake).\nTotal compliance score of MOVIPREP is the average score of the compliance for the first and second litre.", 
                "measure": "Total Compliance Score", 
                "safety_issue": "No", 
                "time_frame": "1 day (the day of colonoscopy)"
            }, 
            {
                "description": "To prevent any potential dehydration risk participants were recommended the intake of at least 500 ml of additional clear liquid (juices without pulp, tea, water) per liter of the Moviprep solution. The amount of additional clear liquid taken is reported for each liter of Moviprep taken.", 
                "measure": "Patient Compliance - Amount of Additional Clear Liquid Consumed", 
                "safety_issue": "No", 
                "time_frame": "1 day (the day of colonoscopy)"
            }, 
            {
                "description": "An AE was a worsening in severity or frequency of a concomitant illness or any new illness diagnosed during the clinical trial period. A serious adverse event (SAE) is any untoward medical occurrence or effect that at any dose results in death; is life threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability / incapacity; is a congenital anomaly / birth defect; is medically important. Severity is a clinical observation and describes the intensity of the event: Mild: Transient symptoms, no interference with daily activities; Moderate: Marked symptoms, moderate interference with daily activities; Severe: Considerable interference with daily activities. Relatedness to study drug was assessed by the Investigator.", 
                "measure": "Percentage of Patients Who Experienced Adverse Events (AEs)", 
                "safety_issue": "Yes", 
                "time_frame": "From first dose of study drug until the end of colonoscopy procedure, maximum of 24 hours."
            }
        ], 
        "source": "Takeda", 
        "sponsors": {
            "collaborator": {
                "agency": "Norgine BV", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Takeda", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}